Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
This article has been cited by
1Prediction of the Active Components and Possible Targets of Xanthii Fructus Based on Network Pharmacology for Use in Chronic Rhinosinusitis
Shun Ding,Tingting Duan,Zhengyang Xu,Dongqin Qiu,Jingren Yan,Zhonglin Mu,Jing Zhao
Evidence-Based Complementary and Alternative Medicine.2022;2022()1
[DOI]
2Recent Progress in Traditional Chinese Medicines and Their Mechanism in the Treatment of Allergic Rhinitis
Dehong Mao,Zhongmei He,Linglong Li,Yuting lei,Maodi Xiao,Huimin Zhang,Feng Zhang,Liaqat Ali
Journal of Healthcare Engineering.2022;2022()1
[DOI]
3Concentration-dependent effects of PM2.5 mass on expressions of adhesion molecules and inflammatory cytokines in nasal mucosa of rats with allergic rhinitis
Ya-Lin Wang,Wei Gao,Yue Li,Yin-Feng Wang
European Archives of Oto-Rhino-Laryngology.2017;274(8)3221
[DOI]
4Simultaneous quantification of atractyloside and carboxyatractyloside in rat plasma by LC-MS/MS: Application to a pharmacokinetic study after oral administration of Xanthii Fructus extract
Hong Pan,Feng Yang,Daiyuan Xiang,Fuguo Shi
Journal of Separation Science.2020;43(3)590
[DOI]
5Effect of Astragalus membranaceus in Ovalbumin-Induced Allergic Rhinitis Mouse Model
Zhong Bing,Du Jin-Tao,Liu Feng,Luo Ba,Liu Ya-Feng,Liu Shi-Xi
American Journal of Rhinology & Allergy.2019;33(4)420
[DOI]
  Feedback 
  Subscribe